Droloxifene (3-Hydroxytamoxifen) is a tamoxifen analogue and orally bioactive SERM (selective estrogen receptor modulator) that acts as an ER agonist in bone and as an ER antagonist in breast tissue.

FLTX1 is a fluorescent Tamoxifen derivative.

Avobenzone (also known as Butyl methoxydibenzoylmethane, BF2AVB) is an oil soluble ingredient widely used in sunscreen products to absorb the full spectrum of UVA rays and a dibenzoylmethane derivative.

PHTPP is an antagonist of the ERβ (Estrogen Receptor).

LSZ-102 is a potent, orally bioactive and selective ERα antagonist and SERD (estrogen receptor degrader) with an IC50 of 0.2 nM has the potential for the treatment of Estrogen Receptor Positive Breast Cancer.

E3 ligase Ligand 5 is an E3 ligase Ligand that can be used in the synthesis of PROTACs (proteolysis targeting chimeras) to engage an E3 ubiquitin ligase.

GSK5182 is a novel, potent, highly specific and orally bioactive inverse agonist of estrogen-related receptor γ (ERRγ) with an IC50 of 79 nM.

Estradiol Benzoate, the 3-benzoylated form of Estradiol, is a prodrug of estradiol which acts as a steroid sex hormone while exhibiting mild anabolic and metabolic properties and increasing blood coagulability.

AZD9496 is a novel, potent, orally bioavailable, and selective estrogen receptor (ERα) downregulator and antagonist with an IC50 of 0.28 nM and a Ki of 0.7 nM.

Acolbifene (also known as EM-652 and SCH-57068) is a novel, potent and selective estrogen receptor modulator/antatonist (SERM) with a IC50 value of 22±3 nM.